Clinical Trials Logo

Endoscopic Ultrasound clinical trials

View clinical trials related to Endoscopic Ultrasound.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT06315439 Completed - Clinical trials for Pancreas Adenocarcinoma

Digital Confocal Microscopy for Real-time Diagnosis of Pancreatic Solid Lesion

Multi-RELAMI
Start date: January 1, 2023
Phase:
Study type: Observational [Patient Registry]

Endoscopic ultrasound-guided (EUS) tissue acquisition is the current standard of care for the diagnosis of pancreatic solid lesions but it is burdened by a non-negligible risk of non-diagnostic or inconclusive results. Ex-vivo fluorescence confocal laser microscopy (FCM) with MAVIG VivaScope® 2500M-G4 could allow real time assessment of adequacy and diagnosis of the sample.

NCT ID: NCT04834193 Completed - Clinical trials for Endoscopic Ultrasound

Wet-suction Versus Slow-pull for EUS-FNB of Solid Lesions

WEST-FNB
Start date: March 29, 2021
Phase: N/A
Study type: Interventional

A randomized cross-over study investigating the impact of two different suction techniques on histological yield and sample quality of specimens collected by endoscopic ultrasound biopsy from solid lesions using histology needles.

NCT ID: NCT03738280 Completed - Clinical trials for Endoscopic Ultrasound

Non-hypovascular Solid Pancreatic Lesions: Role of EUS

LE-VASC
Start date: May 1, 2016
Phase:
Study type: Observational

Vascular pattern of solid pancreatic lesions (SPLs) has been investigated by different abdominal imaging modalities and by contrast-enhanced endoscopic ultrasonography (CE-EUS). Compared with surrounding pancreatic parenchyma three different patterns have been described: hypo-, iso-, and hypervascular. The majority of SPLs are hypovascular, and the diagnostic relevance of hypoenhanced pattern to predict pancreatic adenocarcinoma (PDAC) is well established. Differently, iso- and hypervascular pattern is not specific and can be expressed by several SPLs, with different clinical behavior and management. To date, poor is know about the role of EUS in differential diagnosis of non-hypovascular SPLs and features associated with malignancy.